Literature DB >> 24694926

A window into the intoxicated mind? Speech as an index of psychoactive drug effects.

Gillinder Bedi1, Guillermo A Cecchi2, Diego F Slezak3, Facundo Carrillo3, Mariano Sigman4, Harriet de Wit5.   

Abstract

Abused drugs can profoundly alter mental states in ways that may motivate drug use. These effects are usually assessed with self-report, an approach that is vulnerable to biases. Analyzing speech during intoxication may present a more direct, objective measure, offering a unique 'window' into the mind. Here, we employed computational analyses of speech semantic and topological structure after ±3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy') and methamphetamine in 13 ecstasy users. In 4 sessions, participants completed a 10-min speech task after MDMA (0.75 and 1.5 mg/kg), methamphetamine (20 mg), or placebo. Latent Semantic Analyses identified the semantic proximity between speech content and concepts relevant to drug effects. Graph-based analyses identified topological speech characteristics. Group-level drug effects on semantic distances and topology were assessed. Machine-learning analyses (with leave-one-out cross-validation) assessed whether speech characteristics could predict drug condition in the individual subject. Speech after MDMA (1.5 mg/kg) had greater semantic proximity than placebo to the concepts friend, support, intimacy, and rapport. Speech on MDMA (0.75 mg/kg) had greater proximity to empathy than placebo. Conversely, speech on methamphetamine was further from compassion than placebo. Classifiers discriminated between MDMA (1.5 mg/kg) and placebo with 88% accuracy, and MDMA (1.5 mg/kg) and methamphetamine with 84% accuracy. For the two MDMA doses, the classifier performed at chance. These data suggest that automated semantic speech analyses can capture subtle alterations in mental state, accurately discriminating between drugs. The findings also illustrate the potential for automated speech-based approaches to characterize clinically relevant alterations to mental state, including those occurring in psychiatric illness.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24694926      PMCID: PMC4138742          DOI: 10.1038/npp.2014.80

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  37 in total

1.  Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration.

Authors:  G J H Dumont; F C G J Sweep; R van der Steen; R Hermsen; A R T Donders; D J Touw; J M A van Gerven; J K Buitelaar; R J Verkes
Journal:  Soc Neurosci       Date:  2009       Impact factor: 2.083

2.  Effects of smoked marijuana on human social behavior in small groups.

Authors:  R W Foltin; M W Fischman
Journal:  Pharmacol Biochem Behav       Date:  1988-06       Impact factor: 3.533

3.  A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy").

Authors:  M R Thompson; P D Callaghan; G E Hunt; J L Cornish; I S McGregor
Journal:  Neuroscience       Date:  2007-03-23       Impact factor: 3.590

4.  The small world of human language.

Authors:  R Ferrer I Cancho; R V Solé
Journal:  Proc Biol Sci       Date:  2001-11-07       Impact factor: 5.349

5.  Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others.

Authors:  Gillinder Bedi; David Hyman; Harriet de Wit
Journal:  Biol Psychiatry       Date:  2010-10-14       Impact factor: 13.382

6.  Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor.

Authors:  Linnet Ramos; Callum Hicks; Richard Kevin; Alex Caminer; Rajeshwar Narlawar; Michael Kassiou; Iain S McGregor
Journal:  Neuropsychopharmacology       Date:  2013-05-16       Impact factor: 7.853

Review 7.  A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers.

Authors:  G J H Dumont; R J Verkes
Journal:  J Psychopharmacol       Date:  2006-03       Impact factor: 4.153

8.  Amphetamine analogs methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) differentially affect speech.

Authors:  Gina F Marrone; Jennifer S Pardo; Robert M Krauss; Carl L Hart
Journal:  Psychopharmacology (Berl)       Date:  2009-11-17       Impact factor: 4.530

9.  A quantitative philology of introspection.

Authors:  Carlos G Diuk; D Fernandez Slezak; I Raskovsky; M Sigman; G A Cecchi
Journal:  Front Integr Neurosci       Date:  2012-09-24

10.  The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study.

Authors:  Michael C Mithoefer; Mark T Wagner; Ann T Mithoefer; Lisa Jerome; Rick Doblin
Journal:  J Psychopharmacol       Date:  2010-07-19       Impact factor: 4.153

View more
  27 in total

Review 1.  The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals.

Authors:  Philip Kamilar-Britt; Gillinder Bedi
Journal:  Neurosci Biobehav Rev       Date:  2015-09-25       Impact factor: 8.989

Review 2.  REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.

Authors:  R L Carhart-Harris; K J Friston
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

3.  Altered Insula Connectivity under MDMA.

Authors:  Ishan C Walpola; Timothy Nest; Leor Roseman; David Erritzoe; Amanda Feilding; David J Nutt; Robin L Carhart-Harris
Journal:  Neuropsychopharmacology       Date:  2017-02-14       Impact factor: 7.853

4.  Thoughts About Disordered Thinking: Measuring and Quantifying the Laws of Order and Disorder.

Authors:  Brita Elvevåg; Peter W Foltz; Mark Rosenstein; Ramon Ferrer-I-Cancho; Simon De Deyne; Eduardo Mizraji; Alex Cohen
Journal:  Schizophr Bull       Date:  2017-05-01       Impact factor: 9.306

5.  Computational Approaches to Behavior Analysis in Psychiatry.

Authors:  Cheryl M Corcoran; Guillermo A Cecchi
Journal:  Neuropsychopharmacology       Date:  2018-01       Impact factor: 7.853

6.  Prediction of psychosis across protocols and risk cohorts using automated language analysis.

Authors:  Cheryl M Corcoran; Facundo Carrillo; Diego Fernández-Slezak; Gillinder Bedi; Casimir Klim; Daniel C Javitt; Carrie E Bearden; Guillermo A Cecchi
Journal:  World Psychiatry       Date:  2018-02       Impact factor: 49.548

7.  Intimate insight: MDMA changes how people talk about significant others.

Authors:  Matthew J Baggott; Matthew G Kirkpatrick; Gillinder Bedi; Harriet de Wit
Journal:  J Psychopharmacol       Date:  2015-04-28       Impact factor: 4.153

8.  Speech-based markers for posttraumatic stress disorder in US veterans.

Authors:  Charles R Marmar; Adam D Brown; Meng Qian; Eugene Laska; Carole Siegel; Meng Li; Duna Abu-Amara; Andreas Tsiartas; Colleen Richey; Jennifer Smith; Bruce Knoth; Dimitra Vergyri
Journal:  Depress Anxiety       Date:  2019-04-22       Impact factor: 6.505

Review 9.  Using Language Processing and Speech Analysis for the Identification of Psychosis and Other Disorders.

Authors:  Cheryl Mary Corcoran; Guillermo A Cecchi
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2020-06-14

Review 10.  Considering the context: social factors in responses to drugs in humans.

Authors:  Harriet de Wit; Michael Sayette
Journal:  Psychopharmacology (Berl)       Date:  2018-02-22       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.